| Kyle Patrick Hornsby, MD | |
|
550 S Landmark Ave, Bloomington, IN 47403-3239 | |
| (812) 331-3401 | |
| (812) 335-0027 |
| Full Name | Kyle Patrick Hornsby |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 15 Years |
| Location | 550 S Landmark Ave, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184868838 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Bloomington Hospital | Bloomington, IN | Hospital |
| Indiana University Health Bedford Hospital | Bedford, IN | Hospital |
| Indiana University Health Paoli Hospital | Paoli, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Southern Indiana Physicians Llc | 6204748197 | 449 |
News Archive
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
Neuroscientists at the Hebrew University of Jerusalem have developed a novel approach for measuring and deciphering brain activity that holds out promise of providing improved movements of natural or artificial limbs by those who have been injured or paralyzed.
A new study led by Mount Sinai researchers in collaboration with scientists from Cornell University and the U.S. Centers for Disease Control and Prevention, has found higher prenatal exposure to phthalates-manmade chemicals that interfere with hormonal messaging-to be connected with disruptive and problem behaviors in children between the ages of 4 and 9 years.
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive mucormycosis (also known as zygomycosis), a life-threatening invasive fungal infection caused by certain emerging molds.
› Verified 1 days ago
| Entity Name | Indiana University Health Southern Indiana Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013953983 PECOS PAC ID: 6204748197 Enrollment ID: O20040423000556 |
News Archive
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
Neuroscientists at the Hebrew University of Jerusalem have developed a novel approach for measuring and deciphering brain activity that holds out promise of providing improved movements of natural or artificial limbs by those who have been injured or paralyzed.
A new study led by Mount Sinai researchers in collaboration with scientists from Cornell University and the U.S. Centers for Disease Control and Prevention, has found higher prenatal exposure to phthalates-manmade chemicals that interfere with hormonal messaging-to be connected with disruptive and problem behaviors in children between the ages of 4 and 9 years.
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive mucormycosis (also known as zygomycosis), a life-threatening invasive fungal infection caused by certain emerging molds.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Patrick Hornsby, MD 550 S Landmark Ave, Bloomington, IN 47403-3239 Ph: (812) 331-3401 | Kyle Patrick Hornsby, MD 550 S Landmark Ave, Bloomington, IN 47403-3239 Ph: (812) 331-3401 |
News Archive
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
Neuroscientists at the Hebrew University of Jerusalem have developed a novel approach for measuring and deciphering brain activity that holds out promise of providing improved movements of natural or artificial limbs by those who have been injured or paralyzed.
A new study led by Mount Sinai researchers in collaboration with scientists from Cornell University and the U.S. Centers for Disease Control and Prevention, has found higher prenatal exposure to phthalates-manmade chemicals that interfere with hormonal messaging-to be connected with disruptive and problem behaviors in children between the ages of 4 and 9 years.
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive mucormycosis (also known as zygomycosis), a life-threatening invasive fungal infection caused by certain emerging molds.
› Verified 1 days ago
Wai Pok Vernon Chan, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-676-4102 Fax: 812-676-4106 | |
Dr. Kevin Edward Zawacki, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1312 W. Arch Haven Avenue, Bloomington, IN 47403 Phone: 812-676-4144 Fax: 812-339-8344 | |
Mr. Rana Zouveenoor Tariq, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1312 W Arch Haven Ave, Bloomington, IN 47403 Phone: 812-676-4144 | |
Dr. Samuel W Kimani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-331-3400 Fax: 812-332-7265 | |
Dr. Simeon Zou, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 583 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-676-4460 Fax: 812-355-4092 | |
Shelby Renee Tipton, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2905 N Stone Carver Dr, Bloomington, IN 47404 Phone: 812-676-4715 | |
Ms. Louise Anne Owens, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 S Madison St, Bloomington, IN 47403 Phone: 812-334-3303 Fax: 812-334-0842 |